Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.56 USD | +1.70% | +1.76% | -16.29% |
Apr. 24 | Oppenheimer Adjusts Incyte Price Target to $84 From $92, Maintains Outperform Rating | MT |
Apr. 23 | Transcript : Escient Pharmaceuticals, Inc., Incyte Corporation - M&A Call |
Trading Ideas
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- Trading Ideas